C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.22, 195/1.
C12N 15/19 (2006.01) A61K 51/08 (2006.01) C07K 14/52 (2006.01) C07K 14/55 (2006.01) C07K 14/565 (2006.01) C12N 15/10 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1340861
Muteins of biologically active proteins such as IFN-.beta. and IL-2 in which cysteine residues that are not essential to biological activity have been replaced with other amino acids, or in the case of IFN-.beta. deleted or replaced with other amino acids, to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins are made via bacterial expression of mutant genes that encode the muteins that have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.
438878
Lin S. Leo
Lu Shi-Da Yu
Mark F. David
Borden Ladner Gervais Llp
Cetus Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Cysteine-depleted muteins of biologically active proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cysteine-depleted muteins of biologically active proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine-depleted muteins of biologically active proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1180168